139 related articles for article (PubMed ID: 6386149)
1. Analysis of antigenic expression by primary and autologous metastatic human sarcomas using murine monoclonal antibodies.
Roth JA; Restrepo C; Scuderi P; Baldwin RW; Reichert CM; Hosoi S
Cancer Res; 1984 Nov; 44(11):5320-5. PubMed ID: 6386149
[TBL] [Abstract][Full Text] [Related]
2. Human tumor-associated antigens detected by serological techniques: analysis of autologous humoral immune responses to primary and metastatic human sarcomas by an enzyme-linked immunoabsorbent solid-phase assay (ELISA).
Roth JA; Wesley RA
Cancer Res; 1982 Oct; 42(10):3978-86. PubMed ID: 6955005
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas.
Yoshida SO; Imam A
Cancer Res; 1989 Apr; 49(7):1802-9. PubMed ID: 2466563
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to production of antitumor monoclonal antibodies: antibody to a cell surface glycoprotein associated with transformation by a human oncogene.
Roth JA; Scuderi P; Westin E; Gallo RC
Surgery; 1984 Aug; 96(2):264-72. PubMed ID: 6379959
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR (Ia-like) reactivity in tumors of bone and soft tissue: an immunohistochemical comparison of monoclonal antibodies LN3 and LK8D3 in routinely processed specimens.
Swanson PE; Wick MR
Mod Pathol; 1990 Mar; 3(2):113-9. PubMed ID: 1691491
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
[TBL] [Abstract][Full Text] [Related]
9. Detection of a human sarcoma-associated antigen with monoclonal antibodies.
Brown JM
Cancer Res; 1983 May; 43(5):2113-20. PubMed ID: 6299540
[TBL] [Abstract][Full Text] [Related]
10. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies.
Fargion S; Carney D; Mulshine J; Rosen S; Bunn P; Jewett P; Cuttitta F; Gazdar A; Minna J
Cancer Res; 1986 May; 46(5):2633-8. PubMed ID: 3008997
[TBL] [Abstract][Full Text] [Related]
12. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.
Natali PG; Cavaliere R; Bigotti A; Nicotra MR; Russo C; Ng AK; Giacomini P; Ferrone S
J Immunol; 1983 Mar; 130(3):1462-6. PubMed ID: 6600484
[TBL] [Abstract][Full Text] [Related]
13. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody identification and characterization of two human sarcoma-associated antigens.
Stastny JJ; Brown JM; Beattie CW; Das Gupta TK
Cancer Res; 1991 Jul; 51(14):3768-73. PubMed ID: 2065331
[TBL] [Abstract][Full Text] [Related]
15. Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors.
Byers VS; Johnston JO
Cancer Res; 1977 Sep; 37(9):3173-83. PubMed ID: 69491
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.
Croghan GA; Papsidero LD; Valenzuela LA; Nemoto T; Penetrante R; Chu TM
Cancer Res; 1983 Oct; 43(10):4980-8. PubMed ID: 6349797
[TBL] [Abstract][Full Text] [Related]
17. Detection of human osteosarcoma-associated antigen(s) by monoclonal antibodies.
Hosoi S; Nakamura T; Higashi S; Yamamuro T; Toyama S; Shinomiya K; Mikawa H
Cancer Res; 1982 Feb; 42(2):654-9. PubMed ID: 6173116
[TBL] [Abstract][Full Text] [Related]
18. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas.
Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD
Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]